Total medical devices industry M&A deals worth $831.84m were announced in the US in February 2021, with Veracyte’s $600m acquisition of Decipher Biosciences being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 96.2% over the previous month of $22.04bn and a drop of 87.9% when compared with the last 12-month average of $6.9bn.
The US held a 96.52% share of the global medical devices industry M&A deal value that totalled $861.84m in February 2021.
In terms of M&A deal activity, the US recorded 28 deals during February 2021, marking a decrease of 12.50% over the previous month and a rise of 33.33% over the 12-month average.
US medical devices industry M&A deals in February 2021: Top deals
The top five medical devices industry M&A deals accounted for 99.6% of the overall value during February 2021.
The combined value of the top five medical devices M&A deals stood at $828.34m, against the overall value of $831.84m recorded for the month.
The top five medical devices industry M&A deals of February 2021 tracked by GlobalData were:
1) Veracyte’s $600m acquisition of Decipher Biosciences
2) The $150m acquisition of Simplify Medical by NuVasive
3) Mind Medicine MindMed’ $32.66m acquisition of HealthMode.
4) The $23.68m acquisition of Chronix Biomedical by OncoCyte
5) Volpara Solutions’ acquisition of CRA Health for $22m.
